Estructura del grupo
8 empresas en 2 países
Brasil6
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Cargando la página…
Cargando la página…
8 empresas en 2 países
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 38
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| CEFTAZIDIME1gm/vial | 2gm/vial | 500mg/vial | 6gm/vial · Injectable | Ceftazidime | Estados Unidos | Comercializado | 1985 |
| ERTAPENEM ACS DOBFARPolvere per concentrato per soluzione per infusione | Ertapenem | Italia | Autorizado | |
| KEFUROX1.5gm base/vial | 7.5gm base/vial · Injectable | Cefuroxime | Estados Unidos | No comercializado | 1986 |
| KEFUROX750mg base/vial · Injectable | Cefuroxime | Estados Unidos | No comercializado | 1986 |
| KEFZOL10gm base/vial | 1gm base/vial | 20gm base/vial | 250mg base/vial | 500mg base/vial · Injectable | Cefazolin | Estados Unidos | No comercializado | 1973 |
| MEROPENEM1gm/vial | 500mg/vial · Injectable | Meropenem | Estados Unidos | Comercializado | 2010 |
| MEROPENEM ACS DOBFARPolvere per soluzione iniettabile/per infusione | Meropenem | Italia | Autorizado | |
| CECLOR 125MG-5ML SUSP | Cefaclor | Arabia Saudí | Autorizado | |
| CECLOR 250 MG-5ML SUSP | Cefaclor | Arabia Saudí | Autorizado | |
| CECLOR 250MG CAPSULE | Cefaclor | Arabia Saudí | Autorizado | |
| CECLOR 500MG CAPSULE | Cefaclor | Arabia Saudí | Autorizado | |
| CECLOR MR 375 MG TAB | Cefaclor | Arabia Saudí | Autorizado | |
| CECLOR MR 500MG TAB | Cefaclor | Arabia Saudí | Autorizado | |
| CECLOR MR 750 MG TAB | Cefaclor | Arabia Saudí | Autorizado | |
| Imesta 500 mg/500 mg Powder For IV Infusion (10S) | Cilastatin, Imipenem | Arabia Saudí | Autorizado | |
| Imesta 500 mg/500 mg Powder For IV Infusion (1Vial) | Cilastatin, Imipenem | Arabia Saudí | Autorizado | |
| Imipenem/Cilastatin Kabi 500MG/500MG VIAL | Cilastatin | Arabia Saudí | Autorizado | |
| IMIPENEM-CILASTATIN LABATEC 500/500 VIAL | Cilastatin, Imipenem | Arabia Saudí | Autorizado | |
| IVNEM | Cilastatin, Imipenem | Arabia Saudí | Autorizado | |
| KEFLEX 250MG-5ML SUSPENTION | Cefalexin | Arabia Saudí | Autorizado | |
| KEFLEX 500MG TAB | Cefalexin | Arabia Saudí | Autorizado | |
| MERONEM 1GM VIAL I-V | Meropenem | Arabia Saudí | Autorizado | |
| MERONEM 1GM VIAL I-V | Meropenem | Arabia Saudí | Autorizado | |
| MERONEM 500MG VIAL I-V | Meropenem | Arabia Saudí | Autorizado | |
| MERONEM 500MG VIAL I-V | Meropenem | Arabia Saudí | Autorizado |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Arabia Saudí | 31 | 31 | 0 | EmpresasTodos los medicamentos |
| Estados Unidos | 5 | 5 | 0 | EmpresasTodos los medicamentos |
| Italia | 2 | 2 | 0 | EmpresasTodos los medicamentos |
También en los registros de Brasil, Croacia, Francia, Reino Unido, Serbia, Singapur
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licencia: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de ACS en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaLicencia: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci-con-dettaglio-autorizzazioni/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:44.771040+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
Grupos farmacéuticos conocidos, cada uno con todas sus empresas.